Revenues for the second quarter increased by 39 percent to 40.6 MSEK (29.3) and operating profit to 5.2 MSEK (-1.5) compared to previous year. The growth is applicable to both Surgical Instruments (44 percent) and C-arm Tables (35 percent).
"I am pleased to see that demand for our products is returning in all markets where we are active, and it is particularly positive that the growth for both business units is the strongest on the strategically important US market", says CEO Hanna Ernestam Wilkman.
Shortly after the end of the second quarter, Stille acquired
"
Strong Growth In All Markets
- Revenues amounted to 40.6 MSEK (29.3).
- Gross margin amounted to till 45.4 percent (28.9).
- Operating profit amounted to 5.2 MSEK (-1.5), equal to an operating margin of 12.7 percent (-5.1). The operating profit was impacted with -0,8 MSEK (0.0) in transaction costs.
- Net income amounted to 2.7 MSEK (-2.0), equal to 6.7 percent (-7.0) of revenues.
- Cashflow from current operations amounted to -3.0 MSEK (0.6).
MSEK | apr-jun 2021 | apr-jun 2020 | jan-jun 2021 | jan-jun 2020 | jul-jun 20/21 | jan-dec 2020 |
Revenue | 40.6 | 29.3 | 76.4 | 66.1 | 152.9 | 142.6 |
Operating Profit incl. transaction costs | 5.2 | -1.5 | 9.1 | 3.3 | 20.4 | 14.5 |
Operating Margin incl. transaction costs. % | 12.7 | -5.1 | 12.0 | 4.9 | 13.3 | 10.2 |
Profit Before Tax | 4.1 | -2.4 | 9.8 | 3.1 | 17.5 | 10.8 |
Net Income | 2.7 | -2.0 | 6.8 | 2.3 | 12.7 | 8.3 |
Earnings per Share. SEK | 0.57 | -0.42 | 1.40 | 0.48 | 2.63 | 1.71 |
Torshälla,
For more information, please contact:
Hanna Ernestam Wilkman
CEO
+46 (0)72 402 10 88 | hanna.e.wilkman@stille.se
The share is listed on First North Growth Market under the acronym "STIL" with
For more information about Stille visit www.stille.se
https://news.cision.com/stille/r/stille-ab--interim-report-q2-2021,c3385890
https://mb.cision.com/Main/1000/3385890/1445633.pdf
https://mb.cision.com/Public/1000/3385890/94fd678dc1cfe922.pdf
(c) 2021 Cision. All rights reserved., source